From research to market.
Milestones marked as objectives are funded by the current round and have not yet been reached.
R&D begins
Deep Diagnose research starts; university partnership established; advisory board assembled.
First release
A test version of the Deep Diagnose application is released; internal validation begins.
R&D & certification
AI model development and internal validation; CE Class I certification achieved; advisory board expanded.
Commercial preparation
App v2.0 development; team build-out; regulatory strategy finalised.
The evidence machine
3.000-patient clinical trial; CE Class IIa upgrade; DiGA dossier. Investment-funded milestones.
Market launch
Commercial launch in Belgium and the Netherlands; first commercial users.
The people behind it.
James Troch, MSc
Tom De Bast, MSc
Research & data science
Dr. Hendrik Schwagten, PhD
Prof. Dr. Patrick Wessa, PhD
Dr. Iordan Hristov, PhD
Advisory board
To be announced shortly.
Clinical and academic partners.
Deep Medicine is being developed with the help of several clinical and academic partners. If your organisation is interested in joining, contact us.